Multiple doses of sclerostin antibody romosozumab in healthy men and postmenopausal women with low bone mass: A randomized, double-blind, placebo-controlled study
Year: 2013
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
DOI: 10.1002/jcph.239
Authors: Desmond Padhi, Mark Allison, Alan J. Kivitz, Maria J. Gutierrez, Brian Stouch, Christine Wang, Graham Jang
Language: English
Subfield: Orthopedics and Sports Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2153703573
